by Jordana Choucair | May 3, 2022 | Opioid/Substance Use Disorders
Two Representatives sent a letter warning Attorney General Merrick Garland that the deals Teva Pharmaceuticals struck with Texas, Florida, and Rhode Island could create shortages of treatment and opioid reversal drugs in the rest of the country. “These...
by Jordana Choucair | May 3, 2022 | Payers
UnitedHealthcare will limit coverage of Biogen Inc.’s Aduhelm across all of its plans starting June 1, saying it’s “unproven and not medically necessary for the treatment of Alzheimer’s disease due to insufficient evidence of efficacy.”...
by Jordana Choucair | May 3, 2022 | Providers
Kaufman Hall’s latest hospital flash report indicates that outpatient volumes and revenue for hospitals and health systems showed a robust rebound in March. According to the report, outpatient revenue was up 16.7 percent compared to February 2022 and 2.7 percent when...
by Jordana Choucair | May 2, 2022 | Access & Coverage
The Biden administration suspended Georgia Governor Brian Kemp’s plan to block residents from shopping for health insurance coverage on the Affordable Care Act (ACA) marketplace later this year. Under the Kemp plan, when shoppers went to the website to shop for plans,...
by Jordana Choucair | May 2, 2022 | Inequities and SDOH
The American Academy of Pediatrics said it is reviewing all of its treatment recommendations in an effort to eliminate “race-based” medicine. The move is prompted by both civil rights movements and science identifying the link between health outcomes and...
Recent Comments